News

The Impact Journals news page hosts content about important news articles and press releases from our Journals and Editorial Board Members.

News

Mission
The Impact Journals news page hosts articles about important news stories from our journals and within the scientific community. Visit this page for the latest in medical advances, pharmaceutical progress, conference reports, and more.

Oncotarget | In vitro chemotherapy-associated muscle toxicity is attenuated with nutritional support, while treatment efficacy is retained

News

October 11, 2022
PRESS RELEASE: A new Oncotarget research paper was published on October 8, 2022, entitled, “In vitro chemotherapy-associated muscle toxicity is attenuated with nutritional support, while treatment efficacy is retained.” continue reading »

Oncotarget | Genomic alterations predictive of poor clinical outcomes in pan-cancer

News

October 4, 2022
PRESS RELEASE: A new research paper was published in Oncotarget's Volume 13 on September 28, 2022, entitled, “Genomic alterations predictive of poor clinical outcomes in pan-cancer.” continue reading »

Aging | Psychological factors substantially contribute to biological aging: evidence from the aging rate in Chinese older adults

Aging

October 3, 2022
PRESS RELEASE: A new research paper was published on the cover of Aging’s Volume 14, Issue 18, entitled, “Psychological factors substantially contribute to biological aging: evidence from the aging rate in Chinese older adults.” continue reading »

Genes & Cancer | Reaching beyond family history as inclusion criteria for pancreatic cancer surveillance in high-risk populations

Genes & Cancer

September 30, 2022
PRESS RELEASE: A new editorial paper was published in Genes & Cancer on August 29, 2022, entitled, “Reaching beyond family history as inclusion criteria for pancreatic cancer surveillance in high-risk populations.” continue reading »

Oncotarget | Site of analysis matters – Ongoing complete response to Nivolumab in a patient with HIV/HPV related metastatic anal cancer and MLH1 mutation

News

September 29, 2022
PRESS RELEASE: A new Oncotarget research paper was published, entitled, “Site of analysis matters - Ongoing complete response to Nivolumab in a patient with HIV/HPV related metastatic anal cancer and MLH1 mutation.” continue reading »